Mainz Price To Free Cash Flows Ratio from 2010 to 2024

MYNZ Stock  USD 0.22  0.04  15.38%   
Mainz Biomed Price To Free Cash Flows Ratio yearly trend continues to be fairly stable with very little volatility. Price To Free Cash Flows Ratio will likely drop to -0.83 in 2024. During the period from 2010 to 2024, Mainz Biomed Price To Free Cash Flows Ratio regression line of annual values had significance of  0.0001 and arithmetic mean of (197.14). View All Fundamentals
 
Price To Free Cash Flows Ratio  
First Reported
2010-12-31
Previous Quarter
(0.79)
Current Value
(0.83)
Quarterly Volatility
125.42114259
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Mainz Biomed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mainz Biomed's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 1.1 M or Interest Expense of 419.9 K, as well as many indicators such as Price To Sales Ratio of 19.99, Dividend Yield of 0.0 or PTB Ratio of 6.09. Mainz financial statements analysis is a perfect complement when working with Mainz Biomed Valuation or Volatility modules.
  
Check out the analysis of Mainz Biomed Correlation against competitors.

Latest Mainz Biomed's Price To Free Cash Flows Ratio Growth Pattern

Below is the plot of the Price To Free Cash Flows Ratio of Mainz Biomed BV over the last few years. It is Mainz Biomed's Price To Free Cash Flows Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mainz Biomed's overall financial position and show how it may be relating to other accounts over time.
Price To Free Cash Flows Ratio10 Years Trend
Slightly volatile
   Price To Free Cash Flows Ratio   
       Timeline  

Mainz Price To Free Cash Flows Ratio Regression Statistics

Arithmetic Mean(197.14)
Coefficient Of Variation(63.62)
Mean Deviation111.65
Median(280.87)
Standard Deviation125.42
Sample Variance15,730
Range280
R-Value0.83
Mean Square Error5,208
R-Squared0.69
Significance0.0001
Slope23.34
Total Sum of Squares220,226

Mainz Price To Free Cash Flows Ratio History

2024 -0.83
2023 -0.79
2022 -6.52
2021 -23.15
2020 -117.09

About Mainz Biomed Financial Statements

Mainz Biomed investors use historical fundamental indicators, such as Mainz Biomed's Price To Free Cash Flows Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Mainz Biomed. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price To Free Cash Flows Ratio(0.79)(0.83)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Mainz Stock Analysis

When running Mainz Biomed's price analysis, check to measure Mainz Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mainz Biomed is operating at the current time. Most of Mainz Biomed's value examination focuses on studying past and present price action to predict the probability of Mainz Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mainz Biomed's price. Additionally, you may evaluate how the addition of Mainz Biomed to your portfolios can decrease your overall portfolio volatility.